Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Wenzel

Showing results (171-180 of 213) with videos related to

Pageof 22
Sort By:
Medicina (Kaunas, Lithuania)|June 28, 2023
Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Clara Humke, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 10, 2020
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinomaLuigi Nocera, Lara F Stolzenbach, Claudia Collà Ruvolo, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision MakingPhilipp Mandel, Mike Wenzel, Benedikt Hoeh, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Urethral Sphincter Length but Not Prostatic Apex Shape in Preoperative MRI Is Associated with Mid-Term Continence Rates after Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Matthias Müller, et al.
Journal of Cancer Research and Clinical Oncology|August 24, 2024
Epigenetic profiling of prostate cancer reveals potential prognostic signaturesSimon Bernatz, Ian G Reddin, Tim R Fenton, et al.
European Urology Focus|December 28, 2020
Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate BiopsyMike Wenzel, Maria N Welte, Lena H Theissen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2021
Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysisMike Wenzel, Marina Deuker, Luigi Nocera, et al.
International Urology and Nephrology|April 16, 2026
Racial/ethnic differences in time to nephrectomy and its association with cancer-specific mortality in localized renal cell carcinomaMaximilian Filzmayer, Federico Polverino, Michele Petix, et al.
Journal of Racial and Ethnic Health Disparities|June 13, 2026
Survival Differences of Localized Papillary Renal Cell Carcinoma in African Americans vs. European AmericansMaximilian Filzmayer, Federico Polverino, Michele Petix, et al.
Diagnostics (Basel, Switzerland)|May 13, 2023
External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Mattia Luca Piccinelli, et al.
Pageof 22

Showing results (171-180 of 213) with videos related to

Sort By:
Pageof 22
Medicina (Kaunas, Lithuania)|June 28, 2023
Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Clara Humke, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 10, 2020
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinomaLuigi Nocera, Lara F Stolzenbach, Claudia Collà Ruvolo, et al.
Current Oncology (Toronto, Ont.)|July 2, 2021
Immunohistochemistry for Prostate Biopsy-Impact on Histological Prostate Cancer Diagnoses and Clinical Decision MakingPhilipp Mandel, Mike Wenzel, Benedikt Hoeh, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Urethral Sphincter Length but Not Prostatic Apex Shape in Preoperative MRI Is Associated with Mid-Term Continence Rates after Radical ProstatectomyBenedikt Hoeh, Mike Wenzel, Matthias Müller, et al.
Journal of Cancer Research and Clinical Oncology|August 24, 2024
Epigenetic profiling of prostate cancer reveals potential prognostic signaturesSimon Bernatz, Ian G Reddin, Tim R Fenton, et al.
European Urology Focus|December 28, 2020
Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate BiopsyMike Wenzel, Maria N Welte, Lena H Theissen, et al.
European Journal of Cancer (Oxford, England : 1990)|August 15, 2021
Median time to progression with TKI-based therapy after failure of immuno-oncology therapy in metastatic kidney cancer: A systematic review and meta-analysisMike Wenzel, Marina Deuker, Luigi Nocera, et al.
International Urology and Nephrology|April 16, 2026
Racial/ethnic differences in time to nephrectomy and its association with cancer-specific mortality in localized renal cell carcinomaMaximilian Filzmayer, Federico Polverino, Michele Petix, et al.
Journal of Racial and Ethnic Health Disparities|June 13, 2026
Survival Differences of Localized Papillary Renal Cell Carcinoma in African Americans vs. European AmericansMaximilian Filzmayer, Federico Polverino, Michele Petix, et al.
Diagnostics (Basel, Switzerland)|May 13, 2023
External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Mattia Luca Piccinelli, et al.
Pageof 22